{"id":14468,"date":"2012-01-19T10:30:00","date_gmt":"2012-01-19T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/mmg-obbligati-a-specificare-in-ricetta-lequivalente-milillo-una-forzatura\/"},"modified":"2012-01-19T10:30:00","modified_gmt":"2012-01-19T09:30:00","slug":"mmg-obbligati-a-specificare-in-ricetta-lequivalente-milillo-una-forzatura","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/mmg-obbligati-a-specificare-in-ricetta-lequivalente-milillo-una-forzatura\/","title":{"rendered":"Mmg forced to specify the equivalent in the recipe. Millillo: a stretch"},"content":{"rendered":"

Family doctors will be obliged, except in particular situations, to specify in the medical prescription the possible existence of an equivalent drug. This would be one of the innovations contained in the new draft of the Decree on liberalization being studied by the Government. \u00abUnless there are therapeutic reasons to the contrary in the specific case\u00bb the draft reads \u00abthe doctor inserts the following words in each medical prescription: "or equivalent drug if cheaper", or specifies the existence of the equivalent drug\u00bb. A rule that arouses the reaction of the Fimmg: "It seems absurd to me" is the comment of Giacomo Milillo, secretary of the Fimmg, who expresses his intention to contest the rule "it's a stretch, I'm amazed". "A truly significant step to remove one of the main bottlenecks of healthcare spending" is the opinion of Giorgio Foresti, president of Assogenerici. \u00abAs far as we know now\u00bb continues Foresti \u00abthe text should also contain measures aimed at eliminating possible disputes and delays of various kinds at the time of placing new equivalent drugs on the market. It goes without saying that these are two indispensable elements to ensure that Italy quickly reaches a structure of pharmaceutical consumption similar to that of the rest of Europe\u00bb.<\/p>\n

<\/font><\/font><\/p>\n

January 19, 2012 \u2013 DoctorNews<\/font><\/em><\/font><\/p>\n

<\/p>\n

Liberalizations: Assogeneric, forcing to say that equivalents are not effective as brands<\/p>\n

<\/span><\/strong><\/p>\n

last update: January 19th, 2.44 pm<\/p>\n

<\/span><\/p>\n

Rome, 19 January (Adnkronos\/Adnkronos Salute) \u2013 "If on the eve of 2012 there is still someone who questions the equivalence between generic drugs and branded drugs, it means that the road is still very long for our sector. If we then support it is the secretary of one of the major family doctors' unions, such statements risk becoming more than anything else psychological terrorism towards patients". Thus Giorgio Foresti, president of Assogenerici, replies to the declarations of the general secretary of Fimmg, Giacomo Milillo, on the first anticipations of the content of the decree on liberalisations.<\/font><\/span><\/p>\n

<\/span><\/p>\n

 <\/p>\n<\/p>\n

<\/font><\/font><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

I medici di famiglia saranno obbligati, salvo particolari situazioni, a specificare nella ricetta medica l’eventuale esistenza del farmaco equivalente. Sarrebbe questa una delle novità, contenute nella nuova bozza del Decreto sulle liberalizzazioni allo studio del Governo. «Il medico, a meno che non sussistano ragioni terapeutiche contrarie nel caso specifico» si legge nella bozza «inserisce in …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14468"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14468\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}